Evidence map›Paper›PMID 35807364›Full record

ArticleMolecules (Basel, Switzerland)2022

A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus.

Renato A da Costa, João A P da Rocha, Alan S Pinheiro, Andréia do S S da Costa, Elaine C M da Rocha, Rai C Silva, Arlan da S Gonçalves, Cleydson B R Santos, Davi do S B Brasil

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Identification of Potential NewInternational journal of molecular sciences · 2022
    Article
  12. Identification of Potential Insect Growth Inhibitor againstInternational journal of molecular sciences · 2022
    Article
  13. Protein Abundance of Drug Transporters in Human Hepatitis C Livers.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Renato A da CostaGraduate Program in Science and Environment, Institute of Exact and Natural Sciences, Federal University of Pará (UFPA), Belém 66075-110, PA, Brazil.
João A P da RochaFederal Institute of Education, Science and Technology of Pará-Campus Bragança, Bragança 68600-000, PA, Brazil.
Alan S PinheiroGraduate Program in Science and Environment, Institute of Exact and Natural Sciences, Federal University of Pará (UFPA), Belém 66075-110, PA, Brazil.ORCID 0000-0003-4339-6765
Andréia do S S da CostaGraduate Program in Science and Environment, Institute of Exact and Natural Sciences, Federal University of Pará (UFPA), Belém 66075-110, PA, Brazil.
Elaine C M da RochaFederal Institute of Education, Science and Technology of Pará-Campus Bragança, Bragança 68600-000, PA, Brazil.
Rai C SilvaDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14040-901, SP, Brazil.ORCID 0000-0003-1774-4164
Arlan da S GonçalvesFederal Institute of Education, Science and Technology of Espírito Santo, Vila Velha 29106-010, ES, Brazil.
Cleydson B R SantosLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.ORCID 0000-0002-0271-335X
Davi do S B BrasilGraduate Program in Science and Environment, Institute of Exact and Natural Sciences, Federal University of Pará (UFPA), Belém 66075-110, PA, Brazil.
Instituto Federal de Educação, Ciência e Tecnologia do Pará · BRUniversidade Federal do Pará · BRInstituto Federal do Espírito Santo · BRUniversidade de Ribeirão Preto · BRUniversidade Federal do Amapá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus (DENV) is a danger to more than 400 million people in the world, and there is no specific treatment. Thus, there is an urgent need to develop an effective method to combat this pathology. NS2B/NS3 protease is an important biological target due it being necessary for viral replication and the fact that it promotes the spread of the infection. Thus, this study aimed to design DENV NS2B/NS3pro allosteric inhibitors from a matrix compound. The search was conducted using the Swiss Similarity tool. The compounds were subjected to molecular docking calculations, molecular dynamics simulations (MD) and free energy calculations. The molecular docking results showed that two compounds, ZINC000001680989 and ZINC000001679427, were promising and performed important hydrogen interactions with the Asn152, Leu149 and Ala164 residues, showing the same interactions obtained in the literature. In the MD, the results indicated that five residues, Lys74, Leu76, Asn152, Leu149 and Ala166, contribute to the stability of the ligand at the allosteric site for all of the simulated systems. Hydrophobic, electrostatic and van der Waals interactions had significant effects on binding affinity. Physicochemical properties, lipophilicity, water solubility, pharmacokinetics, druglikeness and medicinal chemistry were evaluated for four compounds that were more promising, showed negative indices for the potential penetration of the Blood Brain Barrier and expressed high human intestinal absorption, indicating a low risk of central nervous system depression or drowsiness as the the side effects. The compound ZINC000006694490 exhibited an alert with a plausible level of toxicity for the purine base chemical moiety, indicating hepatotoxicity and chromosome damage in vivo in mouse, rat and human organisms. All of the compounds selected in this study showed a synthetic accessibility (SA) score lower than 4, suggesting the ease of new syntheses. The results corroborate with other studies in the literature, and the computational approach used here can contribute to the discovery of new and potent anti-dengue agents.

Indexed as

Dengue VirusProtease InhibitorsViral Nonstructural ProteinsAnimalsAntiviral AgentsDEAD-box RNA HelicasesHumansMiceMolecular Docking SimulationNucleoside-TriphosphatasePeptide HydrolasesRatsRNA HelicasesSerine EndopeptidasesViral ProteasesAntiviral AgentsDEAD-box RNA Helicasesnonstructural protein 2B, Dengue virusNS3 protein, flavivirusNucleoside-TriphosphatasePeptide HydrolasesProtease InhibitorsRNA HelicasesSerine EndopeptidasesViral Nonstructural ProteinsViral Proteasesallosteric siteDenguemolecular dockingmolecular dynamics and free energyNS2B/NS3pro

Identifiers

PMID35807364
PMCPMC9268547
OpenAlexW4283660051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.